Semaglutide
Price range: $55.00 through $100.00
Semaglutide by LP Peptides is a research peptide studied primarily for GLP-1 receptor signaling, incretin biology, glucose metabolism, insulin-related pathways, appetite signaling, and metabolic research. Supplied as a laboratory research material with applicable product and batch documentation, Semaglutide is intended strictly for qualified research use and not for human or veterinary use.
Semaglutide ā Research Peptide
| Product Information | Details |
|---|---|
| Product Name | Semaglutide |
| Brand | LP Peptides |
| SKU | SEM |
| Category | Weight Loss & Metabolic Research |
| Research Compound | Semaglutide |
| Specification | Contact LP Peptides for current catalog specification |
| Form | Lyophilized Powder |
| Intended Use | Research Use Only |
| Price | Contact for Current Pricing |
What is Semaglutide?
Semaglutide is a synthetic peptide-based research compound investigated for its activity at the glucagon-like peptide-1 receptor (GLP-1R).
Research involving semaglutide commonly examines GLP-1 receptor signaling, glucose metabolism, appetite-related pathways, energy balance, insulin signaling, and metabolic regulation.
Semaglutide has been extensively studied in metabolic research, making it a commonly referenced compound in investigations of incretin biology and GLP-1-mediated signaling.
LP Peptides supplies semaglutide as a research material intended for qualified laboratory applications, with product identification and batch documentation available according to the applicable product record.
Product Specifications
| Specification | Details |
| Product | Semaglutide |
| SKU | SEM |
| Brand | LP Peptides |
| Compound | Semaglutide |
| Category | Weight Loss & Metabolic Research |
| Form | Lyophilized Powder |
| Intended Use | Qualified Laboratory Research |
| Packaging | Refer to current LP Peptides product record |
Research Applications
Semaglutide may be investigated in laboratory research involving:
- GLP-1 receptor signaling
- Incretin biology
- Glucose metabolism
- Insulin signaling
- Appetite-related signaling
- Energy balance
- Metabolic regulation
- Receptor pharmacology
- Cellular signaling
- Obesity research models
- Type 2 diabetes research models
- Peptide pharmacology
Research applications should follow appropriate laboratory protocols and experimental controls.
Research Context
Semaglutide is a GLP-1 receptor agonist studied for its effects on GLP-1-mediated signaling pathways.
Research may examine how GLP-1 receptor activation influences glucose handling, insulin-related signaling, appetite pathways, gastrointestinal signaling, and energy balance.
Experimental outcomes can differ depending on the model, assay methodology, concentration, study duration, and other experimental variables. Research findings should therefore be interpreted within the context of the specific study design.
Commonly Compared Research Products
Semaglutide may be evaluated alongside other metabolic research compounds, including:
| Related Products |
| Retatrutide 10mg |
| Retatrutide 20mg |
| Retatrutide 30mg |
| Tirzepatide 10mg |
| Tirzepatide 20mg |
| Tirzepatide 30mg |
| Other GLP-1 and incretin research compounds |
Each compound should be evaluated independently according to the research objective and experimental design.
Laboratory Handling
Semaglutide should be handled according to the current product documentation and the laboratory’s established SOP.
Qualified laboratories should:
- Verify product identity and batch information.
- Review the current COA before research use.
- Maintain accurate inventory and batch records.
- Follow appropriate laboratory handling procedures.
- Minimize unnecessary exposure to heat, moisture, and light.
- Document relevant experimental conditions.
Any preparation or experimental procedure should be determined by qualified research personnel using an appropriate validated protocol.
Storage Guidelines
| Storage Condition | Recommendation |
| Lyophilized Product | Follow current lot-specific storage documentation. |
| Environment | Keep dry and protected from excessive heat and light. |
| Handling | Minimize unnecessary exposure to environmental conditions. |
| Documentation | Follow the current COA, product record, and laboratory SOP. |
Lot-specific documentation should take precedence over general catalog information.
Research Safety Information
Semaglutide is an active pharmacological research compound. Laboratory investigations may examine:
- GLP-1 receptor activity
- Incretin signaling
- Glucose regulation
- Insulin-related pathways
- Appetite signaling
- Energy balance
- Metabolic responses
- Receptor-mediated cellular signaling
Researchers should review applicable safety documentation and institutional requirements before handling or incorporating semaglutide into an experiment.
Research Use Disclaimer
Semaglutide supplied by LP Peptides is intended strictly for qualified laboratory research purposes.
This product:
- Is not intended for human use.
- Is not intended for veterinary use.
- Is not intended for consumption.
- Is not supplied as a treatment or medical product.
- Should only be handled by appropriately qualified research personnel.
Information presented on this page is provided for scientific reference and product identification. It should not be interpreted as medical advice, a treatment recommendation, or a therapeutic claim.
COA & Quality Assurance
Researchers should verify each semaglutide batch using current LP Peptides documentation.
| Quality Checklist |
| Certificate of Analysis (COA) |
| Product identity |
| Batch number |
| Testing date |
| Assay or purity information where applicable |
| Product specification |
| Packaging information |
| Storage requirements |
| Applicable quality-control records |
The current lot-specific documentation takes precedence over general product-page information.
Frequently Asked Questions
| Question | Answer |
| What is Semaglutide? | Semaglutide is a peptide-based research compound investigated primarily for its activity at the GLP-1 receptor. |
| What is Semaglutide studied for? | Research commonly examines GLP-1 signaling, glucose metabolism, insulin-related pathways, appetite signaling, and energy balance. |
| What research category does Semaglutide belong to? | It falls primarily under Weight Loss & Metabolic Research and incretin-related research. |
| Is Semaglutide intended for human use? | No. LP Peptides supplies its research material strictly for qualified laboratory research and not for human or veterinary use. |
| How can I verify a Semaglutide batch? | Review the product SKU, batch number, current COA, product specification, and applicable quality documentation. |
| Can Semaglutide be compared with Tirzepatide? | Researchers may compare compounds involving incretin and metabolic signaling when supported by a defined research objective and appropriate experimental controls. |
| Can Semaglutide be compared with Retatrutide? | Yes, these compounds may be studied within broader metabolic and incretin research, provided each material is documented and evaluated independently. |
| What form is Semaglutide supplied in? | The LP Peptides catalog specification should be checked for the current lot and product configuration. |
Customer Reviews
| Rating | Summary |
| āāāāā | Clear product identification and professional packaging. |
| āāāāā | Product information was straightforward to review. |
| āāāāā | Documentation and batch details were easy to verify. |
| āāāāā | Secure packaging and smooth fulfillment experience. |
Overall Rating: Customer ratings should be based on actual verified purchases and genuine customer feedback.
| Dossage | 10mg*10vials, 15mg*10vials, 20mg*10vials 8, 30mg*10vials, 5mg*10vials |
|---|
Related products
Tesamorelin 10mg
Tesamorelin 10mg (TS10) by LP Peptides is a premium lyophilized research peptide supplied in 10mg Ć 10 vials per box. As a synthetic Growth Hormone-Releasing Hormone (GHRH) analog, TS10 is widely studied in endocrine, metabolic, IGF-1, lipid metabolism, and growth hormone research. Produced with batch-specific quality documentation, it is intended exclusively for qualified laboratory research and not for human or veterinary use.
Tirzepatide 10mg
Tirzepatide 10mg (TR10) by LP Peptides is a premium lyophilized research peptide supplied in 10mg Ć 10 vials per box. As a dual GLP-1 and GIP receptor agonist, TR10 is widely studied in metabolic, obesity, glucose regulation, insulin signaling, appetite regulation, and endocrine research. Produced with batch-specific quality documentation, it is intended exclusively for qualified laboratory research and not for human or veterinary use.